View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREThe launch environment is more pressurized than ever before. The convergence of legislative requirements, payer expectations of price and evidence, and meeting patients’ needs means an aligned launch strategy is mission critical.
This is the first of a three-part series and will focus on the first phase of launch: Acquire.
Successful launches need to plan for success early and carefully by focusing on several key points:
- Patient acquisition first: Drive demand at all (responsible) costs and forecast on patients, not sales.
- Spend on acquisition tactics: Invest in patient support programs, DTC, and transitional assistance programs sooner.
- Align on key metrics: Measure the number of patients and their experiences on product.
- Course correct sooner: With the right mix of data, getting an early launch back on track is possible.
Speakers:
Elyse Muñoz,
Ph.D. Director, U.S. Research & Insights, IQVIA
Brian Lasky
Practice Lead, U.S. Launch Center of Excellence, IQVIA
Nadine Vangelov
Senior Principal, U.S. Launch Center of Excellence, IQVIA
Related solutions
Brand & Marketing
Grow your brand, now and through patent expiry
Compliance & Quality
Navigate the challenge of compliance, and its vital association with quality